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Abstract The Semliki Forest virus (SFV) glycoprotein pre-
cursor p62 is processed to the E2 and E3 during the transport
from the trans-Golgi network (TGN) to the cell surface. We have
studied the regulation of the membrane fusion machinery (Rab/
N-ethylmaleimide (NEM)-sensitive fusion protein (NSF)/soluble
NSF attachment protein (SNAP)^SNAP receptor) in this
processing. Activation of the disassembly of this complex with
recombinant NSF stimulated the cleavage of p62 in permeabi-
lized cells. Inactivation of NSF with a mutant K-SNAP(L294A)
or NEM treatment inhibited processing of p62. Rab GDP
dissociation inhibitor inhibited the cleavage. Inactivation of NSF
blocks the transport of SFV glycoproteins and vesicular
stomatitis virus G-glycoprotein from the TGN membranes to
the cell surface. The results support the conclusion that inhibition
of membrane fusion arrests p62 in the TGN and prevents its
processing by furin. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Multiple membrane fusion events depend on the N-ethyl-
maleimide (NEM)-sensitive factor (NSF), soluble NSF attach-
ment proteins (SNAPs), SNAP receptors (SNAREs), and Rab
GTPases. NSF is a homohexameric ATPase [1,2] which is
stimulated by K-, L- and Q-SNAP [3]. Before NSF can interact
with SNAP isoforms, SNAPs have to be bound to the mem-
brane by SNAREs. NSF, SNAPs, and SNAREs form a stable
20S complex which can be disassembled by the ATPase activ-
ity of NSF [4,5]. The formation and disassembly of the 20S
complex facilitate the fusion of the target and vesicle mem-
branes. Rabs, small GTPases, regulate the tethering/docking
reactions [6]. In this study, we have used bacterial toxin strep-
tolysin O (SLO)-permeabilized cells and in vitro reconstitution
assays to study whether the Rab^NSF^SNAP^SNARE com-
plex is involved in regulation of p62 processing when it is
released from the trans-Golgi network (TGN). Semliki Forest
virus (SFV) is an K-virus widely used in membrane tra⁄c
studies. The SFV spike protein complex consists of two inte-
gral membrane glycoproteins, E1 and E2, and a peripheral
protein E3. The E2/E3 proteins are ¢rst synthesized as a
62 kDa precursor in the endoplasmic reticulum (ER) where
it forms a complex with E1 [7]. During transport to the plas-
ma membrane, where the budding of the virus occurs [8], p62
is cleaved at the C-terminal side of the sequence -Arg-His-
Arg-Arg- [9] most likely by furin which recognizes the con-
sensus sequence Arg-Xaa-(Lys/Arg)-Arg. This cleavage was
¢rst believed to occur on the outer surface of the plasma
membrane because addition of spike protein speci¢c antisera
to the culture medium of virus-infected cells inhibited the
proteolytic processing [10,11]. When p62 is accumulated in
the TGN by the aid of a 20‡C transport block, it remains
uncleaved [12,13]. Studies in permeabilized cells [12] and in
live cells [14] have shown that the processing of p62 takes
place during the transport from the TGN to the plasma mem-
brane. Endocytosis of antibodies against the SFV envelope
glycoproteins as well as antibodies against the enzymatically
active motif of furin inhibited the cleavage, suggesting that
furin and p62 meet each other at an intracellular site distal
to the TGN [14]. As suggested by kinetic experiments this
interaction between the exocytic and endocytic routes occurs
at the level of early endosomes. To obtain further information
on the intracellular processing site, we investigated whether
the membrane fusion machinery is involved in p62 processing.
The results indicate that inhibition of the membrane fusion
machinery by di¡erent means prevents the exit from the TGN
and the cleavage of the SFV p62. Inactivation of NSF in live
cells by NEM treatment or by microinjection of the K-(SNAP)
mutant (L294A) prevents the transport of p62 from the TGN
region to the cell surface.
2. Materials and methods
2.1. Materials
Plasmids encoding the His6-K-SNAP(L294A) mutant and His6-NSF
were gifts from Dr. R. Burgoyne (University of Liverpool, Liverpool,
UK). The His6-GDP dissociation inhibitor (GDI) plasmid was a gift
from Dr. M. Zerial (European Molecular Biology Laboratory, Hei-
delberg, Germany). Plasmids were expressed in Escherichia coli and
recombinant proteins puri¢ed on a Ni-NTA-agarose batch. His6-K-
SNAP and His6-GDI were puri¢ed with modi¢cations as previously
described [15] and His6-NSF according to Whiteheart et al. [16]. Plas-
mid encoding early endosomal autoantigen 1 (EEA1; 1257^1411)-
GST was a gift from Dr. H. Stenmark (Radium Hospital, Montebello,
Norway) and the recombinant protein was puri¢ed according to the
puri¢cation protocol from the manufacturer (Amersham Pharmacia
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Biotech, Uppsala, Sweden). SLO was purchased from Dr. S. Bhakdi
(University of Mainz, Mainz, Germany). Polyclonal antibodies
against SFV glycoprotein E2 [14] were a kind gift from Dr. S. Kera«-
nen (VTT Biotechnology and Food Research, Espoo, Finland). Vesic-
ular stomatitis virus (VSV) tsO45 mutant and polyclonal antiserum
were gifts from Dr. K. Metsikko« (University of Oulu, Oulu, Finland).
Mouse monoclonal anti-rat TGN38 was a gift from Dr. G. Banting
(University of Bristol, Bristol, UK). Mouse monoclonal anti-human
IgG was from Medix Biochemica (Kauniainen, Finland). Lissamine
rhodamine (LRSC)-conjugated and £uorescein (FITC)-conjugated
antibodies were purchased from Jackson Immuno Research (West
Grove, PA, USA). All other reagents were of analytical grade and
were obtained from commercial sources.
2.2. Viral infection and pulse-chase experiments
BHK21 cells were infected with the wild type SFV as described
previously [17]. Pulse labeling with [35S]methionine and immunopre-
cipitation with SFV-E2 speci¢c antiserum were performed according
to Sariola et al. [14]. The gels were dried and exposed to Fuji¢lm
Imaging Plate and analyzed with Bio-Imaging Analyzed Bas-1500
(Fuji Photo Film Co., Ltd., Japan). Images were quantitated using
Tina version 2.09c software (Isotopenmessgera«te GmbH, Germany).
The percentage of the cleavage of p62 at 37‡C was calculated as the
percentage of E2 formed from p62. Some of the p62 leaks out from
the TGN and is cleaved to E2 during the 20‡C block. Therefore E2
produced at 20‡C has to be deducted from E2 formed at 37‡C to be
able to estimate the real cleavage during 37‡C incubation.
2.3. SLO permeabilization
The cells were permeabilized with modi¢cations as previously de-
scribed [18,19]. Transport medium (TM) contained 115 mM K-ace-
tate, 2.5 mM MgCl2, 1 mM dithiothreitol (DTT), 5 mM EGTA,
2.5 mM CaCl2, 25 mM HEPES-KOH pH 7.4. The cytosol extract
was prepared from rat brains in cytosol bu¡er (155 mM K-acetate,
3.5 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.1 mM phenylmethyl-
sulphonyl £uoride, 25 mM HEPES-KOH pH 7.4) according to Miller
and Moore [20]. The ATP regenerating system was 1 mM ATP, 8 mM
phosphocreatine, 50 Wg/ml creatine phosphokinase.
2.4. Microinjection and immunocytochemistry
BHK21 and NRK cells were grown as con£uent monolayers on
coverslips and infected with the SFV ts-1 mutant as previously re-
ported [17]. The rabbit polyclonal antiserum against the 29S complex
of SFV spike glycoproteins was prepared as described [21]. VSV tsO45
mutant infection was performed as previously described [22]. The
polyclonal antiserum against VSV G-protein has been described by
Metsikko« et al. [23]. 300^400 cells were microinjected on each cover-
slip (three coverslips/experiment) with test substances. K-SNAP mu-
tant concentration was 2^3 mg/ml. Microinjections were performed
using an Eppendorf semi-automated micromanipulator injector
(Transjector 5246) with femtotip needles (Eppendorf-Netheler-Hinz
GmbH, Hamburg, Germany). Conventional £uorescence images
were viewed using an Olympus AX70 £uorescence microscope
(U60; 1.4 NA) with a SenSys CCD camera (Photometrics, Ltd., Mu-
nich, Germany). Images were converted using the Image-Pro Plus
version 3.0 software (Media Cybernetics, Silver Spring, MD, USA).
Confocal laser scanning microscopy was performed on a Bio-Rad
MRC-1024 system (Bio-Rad Laboratories, Hercules, CA, USA) at-
tached to an Axiovert 135 M compound microscope (Carl Zeiss, Inc.,
Thornwood, NY, USA) (U100; 1.4 NA). Confocal images were con-
verted using LaserSharp MRC-1024 software (Bio-Rad Laboratories,
Hercules, CA, USA).
3. Results
3.1. NEM inhibits the processing of p62
We have studied involvement of the membrane fusion ma-
chinery in the cleavage of the SFV spike glycoproteins pre-
cursor p62 to E2 and E3 in BHK cells. When the cells are
infected with SFV, and labeled viral glycoproteins are accu-
mulated at 20‡C in the TGN, there is no cleavage of p62 (Fig.
1A). The cleavage of p62 occurs when the 20‡C transport
block is released by increasing the temperature to 37‡C (Fig.
Fig. 1. The cleavage of SFV p62 in BHK21 cells. A: The cells were
infected with SFV and pulse-labeled for 10 min with
[35S]methionine. The labeled virus glycoproteins were accumulated
in the TGN by incubating the cells at 20‡C for 2 h. No cleavage of
p62 occurs. When the transport block is released by increasing the
temperature to 37‡C for 2 h, p62 is cleaved to E2 and E3. The
analysis of the cleavage was carried out by immunoprecipitation of
p62 and E2 and separation by 10% SDS^PAGE. The upper panel
shows quantitation by phosphoimager of the p62 and E2 bands
seen in the lower panel. The cleavage is inhibited in the presence of
1 mM NEM. NEM treatment was performed by incubating the cells
¢rst for 90 min at 20‡C then NEM was added and the cells were
further incubated for 30 min at 20‡C and then for 2 h at 37‡C. The
cleavage of p62 in the control was 88%. B: The labeled virus glyco-
proteins were accumulated in the TGN and the cells were permeabi-
lized with SLO followed by incubation at 37‡C for 2 h in the pres-
ence of TM, cytosol, or cytosol with ATP regeneration system. The
amount of cleavage of p62 in the complete medium was expressed
as 100%. The cleavage of p62 in control was 28%. Values are means
þ S.E.M., n = 4 observations. Data are representative of two similar
experiments.
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1A) [12,14]. The possible role of the membrane fusion, occur-
ring before the processing of the TGN-accumulated p62, was
studied by using a sulphydryl alkylating reagent NEM. NEM
has been reported to inactivate the membrane fusion compo-
nent NSF [24] as well as membrane transport in several sys-
tems such as between the ER and the Golgi stacks [25] and
intra-Golgi transport [26]. In intact BHK cells 1 mM NEM
totally blocked the cleavage of p62 indicating the possible
involvement of membrane fusion before processing of the
TGN-located precursor (Fig. 1A).
3.2. Reconstitution of p62 cleavage in SLO-permeabilized cells
We studied the cleavage of SFV p62 to E2 and E3 further
by using SLO-permeabilized BHK cells. SFV-infected BHK
cells were ¢rst pulse-labeled and chased for 2 h at 20‡C to
accumulate labeled glycoproteins in the TGN. The cells were
then SLO-permeabilized and further incubated for 2 h at 37‡C
to allow the transport of the spike glycoproteins to the plasma
membrane. When the SLO-permeabilized cells were incubated
in the TM, the cleavage of p62 did not take place (Fig. 1B). In
the presence of cytosol and ATP regeneration system, about
30% of p62 was cleaved. In intact cells the cleavage was about
70% on average. Cleavage of p62 was ATP dependent since
only 8% of p62 was cleaved in the absence of ATP regener-
Fig. 2. NSF stimulates the cleavage of SFV p62. BHK cells were in-
fected with SFV, labeled virus glycoproteins were accumulated in
the TGN, and the cells were permeabilized with SLO followed by
incubation at 37‡C for 2 h in the presence of cytosol, ATP regener-
ation system, and NEM (A) or with an increasing concentration of
NSF (0.01, 0.2 or 1 WM) (B). NEM treatment was performed by in-
cubating the cells and cytosol with 1 mM NEM for 15 min at 4‡C
and then quenching with 2 mM glutathione. The cleavage of p62 in
controls (C) was 27% and 28%, respectively. Values are means
þ S.E.M., n = 3^7 observations. *P6 0.01 versus control, Student’s
t-test. Data are representative of two similar experiments.
Fig. 3. The e¡ect of the K-SNAP(L294A) mutant (A) or GDI (B)
on the cleavage of p62. BHK cells were infected with SFV, labeled
virus glycoproteins were accumulated in the TGN, and the cells
were permeabilized with SLO and followed by incubation at 37‡C
for 2 h in the presence of cytosol, ATP regeneration system, and
increasing concentration of the K-SNAP(L294A) mutant (b) or
K-SNAPwt (a) (A) or GDI (B). The cleavage of p62 in controls (A
and B) was 26% and 39%, respectively. Values are means þ S.E.M.,
n = 3 observations or three separate experiments, respectively. Data
are representative of two similar experiments in A.
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ation system when compared with the cleavage of p62 in the
presence of ATP (Fig. 1B).
3.3. Involvement of NSF, K-SNAP and Rabs in the cleavage of
p62
The possible role of NSF in the cleavage of p62 was inves-
tigated by treating the cells and cytosol with NEM. Incubat-
ing cytosol with 1 mM NEM at 4‡C for 15 min did not
repeatedly inhibit cleavage of p62 when added to SLO-per-
meabilized BHK21 cells (data not shown). When both the
cytosol and the cells were treated with NEM, the cleavage
was totally inhibited (Fig. 2A). The recombinant NSF stimu-
lated the cleavage (Fig. 2B), suggesting that NSF is involved
and that it is a rate limiting factor in this system. However,
NSF was unable to reverse the inhibitory e¡ect of NEM. This
could be due to the observation that endogenous NSF re-
mains associated with membranes and that the recombinant
NSF may not be able to replace NEM-inactivated endogenous
NSF as suggested previously [27]. This suggests that mem-
brane bound NSF alone is su⁄cient to support the membrane
fusion step required prior to the p62 cleavage. The tight mem-
brane association of NSF is supported by an experiment with
endocytic vesicles. The stimulation of their fusion by recombi-
nant NSF could only be obtained after removal of endoge-
nous NSF by high salt treatment [28].
K-SNAP stimulates exocytosis in digitonin-permeabilized
adrenal chroma⁄n cells [27]. We used a recombinant K-
SNAP mutant protein (L294A, leucine 294 changed to ala-
nine) that has been reported to be able to bind NSF but not
to stimulate NSF [29]. This mutant caused a dose-dependent
inhibition of the cleavage of p62 in SLO-permeabilized BHK
cells (Fig. 3A). 6 WM K-SNAP mutant inhibited 80% of the
cleavage of p62, indicating that the K-SNAP(L294A) mutant
can replace endogenous K-SNAP and stop membrane fusion.
Wild type K-SNAP had no a¡ect on the processing of p62 at 6
WM (Fig. 3A).
There are over 40 di¡erent Rab GTPases which have been
implicated to play a role in membrane docking [30]. The pos-
sible role of Rabs in the cleavage of p62 was investigated by
using recombinant Rab-GDI. Since Rab-GDI binds to and
inactivates several di¡erent Rabs, it acts as a general regulator
[31]. Rab-GDI has been reported to inhibit intracellular
vesicle tra⁄cking in several systems, for instance between
the ER and Golgi [32], inter-cisternal Golgi transport [33],
and basolateral transport of MDCK cells [34]. In our recon-
stituted system, the addition of 5 WM recombinant Rab-GDI
with the cytosol to SLO-permeabilized cells caused 50% re-
duction in the cleavage of p62 (Fig. 3B), suggesting that a Rab
protein is involved in the membrane fusion/communication
step prior to the p62 processing. This result is in agreement
with a previous report that Rab-GDI inhibited the transport
of SFV glycoproteins E1 and E2 from the TGN to the plasma
membrane in SLO-permeabilized BHK cells [19].
3.4. E¡ect of the K-SNAP mutant on the transport from the
TGN region
Since the results from the reconstitution assays clearly in-
dicated that the membrane fusion machinery is involved in the
C
Fig. 4. The e¡ect of the K-SNAP(L294A) mutant on the localization
of SFV ts-1 glycoproteins. BHK cells were infected with the temper-
ature-sensitive SFV mutant ts-1 (A), viral glycoproteins were accu-
mulated in the TGN at 20‡C (B). The cells were microinjected with
the K-SNAP(L294A) mutant (C, E) or K-SNAPwt (G) together with
monoclonal mouse anti-human IgG as a microinjection marker. The
temperature was raised to 28‡C for 2 h (C^H). The cells were ¢xed
with 3% PFA and permeabilized with 0.05% Triton X-100. The cells
were stained with polyclonal anti-SFV glycoprotein antibody fol-
lowed by LRSC-conjugated goat anti-rabbit IgG. The injector
marker was visualized using FITC-conjugated goat anti-mouse IgG
(C, E, G). Microinjection marker did not a¡ect the transport of the
viral glycoproteins and about 75% of the K-SNAP mutant-microin-
jected cells contained the accumulation of the viral glycoproteins in
the TGN. A shows virus glycoproteins in the ER; B shows virus
glycoproteins in the TGN; C and D represent the same microscopic
¢eld where C shows the K-SNAP(L294A)-microinjected cells and D
shows the localization of virus glycoproteins in those cells; E and F
show another ¢eld (K-SNAP(L294A)-microinjected cells) where F
shows virus glycoproteins on the cell surface before permeabilization
with Triton X-100 to reveal the injection marker (E). G and H rep-
resent the same microscopic ¢eld where G shows the K-SNAPwt-mi-
croinjected cells and H shows the localization of virus glycoproteins
in those cells. Bars, 10 Wm.
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regulation of the cleavage of p62, and since the cleavage of
p62 as such is not required for the transport to the plasma
membrane [35], we wanted to study whether inhibition of
membrane fusion a¡ects the transport of p62 from the
TGN. We studied the transport of p62 from the TGN under
conditions where membrane fusion is inhibited by the
K-SNAP mutant. As shown by in vitro reconstitution experi-
ments, p62 remains uncleaved in the presence of the K-SNAP
mutant. BHK cells were ¢rst infected with a temperature-sen-
sitive SFV ts-1 mutant and incubated at 38.5‡C to arrest SFV
glycoproteins to the ER [21] (Fig. 4A). The SFV proteins were
then allowed to be transported to the TGN at 20‡C [17] (Fig.
4B). After microinjection with the K-SNAP mutant, the low
temperature transport block was released by increasing the
temperature to 28‡C. In the uninjected control cells, the viral
glycoproteins were transported to the plasma membrane (Fig.
4F). The cells injected with the K-SNAP mutant showed
greatly reduced plasma membrane staining of virus glycopro-
tein, indicating that the transport of viral proteins to the cell
surface was markedly inhibited (Fig. 4F). Instead, bright in-
tracellular staining of perinuclear elements was observed
(Fig. 4D).
We used the indirect double staining technique and confo-
cal laser scanning microscopy to study the colocalization of
viral glycoproteins in the perinuclear elements (Fig. 4D) with
the TGN marker TGN38. Because the anti-rat TGN38 anti-
body did not stain BHK cells, NRK cells were used. After 2 h
incubation at 20‡C, colocalization of the viral glycoproteins
and the TGN38 marker was observed in the TGN membranes
(Fig. 5C). After microinjection with the recombinant K-SNAP
mutant protein and incubation for 2 h at 28‡C, the viral
glycoproteins and the TGN38 protein were still mostly colo-
Fig. 5. Colocalization of virus glycoproteins and TGN38 by confo-
cal microscopy. SFV ts-1 mutant viral glycoproteins were accumu-
lated in the TGN in NRK cells cultured on cellogate coverslips.
Cells were microinjected with the K-SNAP(L294A) mutant and incu-
bated further at 28‡C. The cells were ¢xed with 3% PFA and per-
meabilized with 0.05% Triton X-100. The cells were stained with
polyclonal anti-SFV glycoprotein antibody followed by FITC-conju-
gated goat anti-rabbit IgG (A, D) as well as monoclonal anti-
TGN38 and TRITC-conjugated goat anti-mouse IgG (B, E). The
yellow color in C and F reveals the colocalization. Bars, 10 Wm.
Fig. 6. NEM blocks the transport of viral glycoproteins from the
TGN to the plasma membrane as well as from the ER to the TGN.
SFV ts-1-infected BHK cells were incubated at 20‡C for 2 h to ac-
cumulate viral glycoproteins to the TGN (A) and then the tempera-
ture was shifted to 28‡C for 2 h (B). In NEM-treated cells viral gly-
coproteins were ¢rst incubated at 20‡C for 1.5 h and then 1 mM
NEM was added and further incubated at 20‡C for 0.5 h before the
shift to 28‡C (C). Similarly VSV-infected BHK cells were incubated
at 20‡C (D) and shifted to 32‡C in the absence (E) and the presence
of 1 mM NEM (F). G and H show the inhibition of the viral glyco-
protein transport from the ER to the TGN in the presence of
NEM. The infected BHK cells were incubated 30 min with 1 mM
NEM before shifting to 20‡C for 2 h. The cells were ¢xed with 3%
PFA and permeabilized with 0.05% Triton X-100. The cells were
stained with polyclonal anti-SFV glycoproteins antibody or poly-
clonal anti-VSV G antibody followed by LRSC-conjugated goat
anti-rabbit IgG. Bars, 10 Wm.
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calized (Fig. 5F), indicating that the viral protein transport
from the TGN to the plasma membrane was prevented.
A similar inhibitory e¡ect on the protein transport was
observed in NEM-treated cells. As shown by immuno£uores-
cence microscopy NEM (1 mM) blocked the transport of the
SFV glycoproteins from the TGN to the plasma membrane in
intact BHK cells (Fig. 6C). The same TGN export inhibition
by NEM was observed when the VSV tsO45 mutant was used
in the transport assay (Fig. 6F). NEM also inhibited the
transport from the ER to the TGN and caused the vesicula-
tion of the ER membranes (Fig. 6G,H). These results are in
agreement with the previous in vitro transport assays. These
studies have shown that membrane transport between the ER
and Golgi [32] and intra-Golgi transport [33] are inhibited
with NEM.
4. Discussion
Previously it has been shown using reconstitution experi-
ments in SLO-permeabilized MDCK cells that Rab-GDI,
NSF, SNAREs and K-SNAP are involved in the transport
from the TGN to the basolateral plasma membrane but not
to the apical plasma membrane [34]. In addition to dissecting
di¡erent pathways SLO-permeabilized cells can be used to
study separate steps in late biosynthetic transport. In this re-
port, we show that function of the membrane fusion machi-
nery is required for the processing of the SFV p62 precursor
accumulated in the TGN at 20‡C. Inactivation of NSF both
in live cells with NEM, and in SLO-permeabilized cells with
NEM or the K-SNAP mutant (L294A), inhibited the cleavage
of p62 when the low temperature-induced transport block in
the TGN was released. Addition of recombinant NSF to the
reconstitution assay stimulated the processing of p62. More-
over, depletion of Rab-GTPases with recombinant GDI pro-
tein inhibited the processing of p62 when the transport block
was released. We studied also whether p62 was exported from
the TGN in the absence of membrane fusion. For this purpose
we used the SFV ts-1 transport mutant and immuno£uores-
cence assays. Unexpectedly, inhibition of NSF function in live
cells either with NEM treatment or with microinjection of the
K-(SNAP) mutant (L294A) protein inhibited the transport of
SFV glycoproteins from the TGN to the cell surface. Since
previous studies have demonstrated that cleavage of p62 is not
a prerequisite for its transport to the plasma membrane [35], it
appears likely that inhibition of the fusion machinery results
in inhibition of membrane export from the TGN. This con-
clusion was supported by the observation that inactivation of
NSF inhibited also the export of the VSV G-protein from the
TGN. This would suggest either direct or indirect participa-
tion of the fusion machinery in vesicle budding. Although the
involvement of NSF and K-SNAP in SNARE complex disas-
sembly and exocytosis has been well established the exact site
of disassembly of the 20S complex is still unknown. According
to the original SNARE hypothesis the disassembly of 20S
complex by NSF ATPase activity provides the energy for
the fusion and is the last step in membrane fusion [36].
Later other hypotheses have been presented suggesting that
NSF activity is needed after membrane fusion to disassemble
the SNARE complex and to allow the recycling of v-SNAREs
to its membrane of origin [37], or that SNARE complex dis-
assembly occurs before the docking of the vesicle to prime
SNAREs [38]. Recently, more evidence has appeared suggest-
ing a much earlier role for NSF/K-SNAP. For instance, syn-
aptic vesicles and chroma⁄n granules contain most of the
components of the 20S complex including K-SNAP, NSF
v-SNAREs, and t-SNAREs [39^42]. Additionally, the recent
kinetic studies in catecholamine release in chroma⁄n cells
suggest that the disassembly of the 20S complex occurs at
an early stage of vesicle recruitment rather than at the late
step for fusion itself [43]. For these reasons the possible in-
volvement of the NSF and K-SNAP in vesicle budding cannot
be ruled out. The other possibility is that exit from the TGN
is critically dependent on retrograde tra⁄c which supplies
components needed for budding. For example, inhibition of
membrane fusion will prevent recycling of budding factors
from the endosomal recycling compartment to the TGN.
This possibility clearly needs further investigations. In conclu-
sion, the present biochemical and morphological results to-
gether indicate that inhibition of membrane fusion prevents
the exit of p62 from the TGN and its subsequent proteolytic
processing.
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